Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

(2015) C.C. Zouboulis et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Use of biological treatments in patients with hidradenitis suppurativa

(2014) G. Martin-Ezquerra et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

(2013) Alexa B. Kimball et al.   ANNALS OF INTERNAL MEDICINE

Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study

(2012) Florence Canoui-Poitrine et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Hidradenitis Suppurativa

(2012) Gregor B.E. Jemec   NEW ENGLAND JOURNAL OF MEDICINE

A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa

(2011) I. Miller et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment of Hidradenitis Suppurativa With Etanercept Injection

(2010) David R. Adams et al.   ARCHIVES OF DERMATOLOGY

Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial

(2010) Annika Grant et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Risk factors for ulcerative colitis: A population-based, case–control study in Spain

(2008) B. Sicilia et al.   Journal of Crohns & Colitis

Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

(2008) Jean E. Revuz et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY